Sufentanil Citrate · SUFENTANIL CITRATE 50 ug/mL · Injection, Solution · Epidural; Intravenous · Hospira, Inc.
NDC 00409-3382-21 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “other”.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bond Pharmacy INC | SUFENTANIL CITRATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | SUFENTANIL CITRATE 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sufentanil Citrate — NDC 00409-3382-21," retrieved September 3, 2026, https://drugdashboards.com/drug/00409338221.
Free to cite with attribution — see how the data is put together.